Simris Group is a biologics company, engaged in research, development and production of bioactive substances from cyanobacteria and microalgae, for nutraceutical, cosmeceutical and pharmaceutical applications. Our technology provides access to bioactive substances with novel functions, while replacing unsustainable raw materials from endangered marine species and ecosystems. Our headquarters and algae farm are located in Hammenhög, in Sweden’s sunny Österlen. Our commercial department is based in Stockholm. Simris Group AB is a public company and our stock is traded on the Nasdaq First North stock exchange (FNSE:SIMRIS B). http://www.simrisgroup.com http://www.simrisbiologics.com